Market Research Reports and Industry Reports

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in Pharmaceuticals

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in Pharmaceuticals

Summary

GlobalDatas "Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in June 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in June 2017. The industry reported 353 deals worth USD31.7 billion in June 2017, compared to 375 deals worth USD36.8 billion in May 2017. The oncology therapeutics market remained at the top in deal activity in June 2017 with 126 deals. In second place, central nervous system therapeutics market reported 75 deals. Licensing agreements in pharmaceutical and healthcare industry registered a decrease in upfront payments. The segment reported USD130m as upfront payments in June 2017, compared to USD199.7m in May 2017. The number of deals in North America decreased to 223 in June 2017 from 229 in May 2017.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and womens health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary 10
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, June 2017 10
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, June 2017 11
2.2.1 Becton, Dickinson to Raise USD10.5 Billion in Public Offering of Notes 11
2.2.2 Pamplona Capital Management to Acquire Parexel International for USD5 Billion 11
2.2.3 AstraZeneca Prices Public Offering of Notes for USD2 Billion 12
2.2.4 Cardinal Health Raises USD1.15 Billion in Public Offering of 2.616% Notes Due 2022 12
2.2.5 F-star Biotech Enters into Partnership with Merck 12
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, June 2017 14
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, June 2017 15
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 16
3.1 Pharmaceuticals & Healthcare, Global, M&A, June 2017 16
3.1.1 Top M&A Deals in June 2017 17
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, January 2017 - June 2017 17
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, June 2017 19
3.2.1 Top Equity Offering Deals in June 2017 20
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, January 2017 - June 2017 21
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, June 2017 22
3.3.1 Top PE/VC Deals in June 2017 23
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, June 2017 23
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, June 2017 24
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, August 2016-June 2017 26
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, August 2016-June 2017 27
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, June 2017 28
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, January 2017 - June 2017 29
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), June 2017 30
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, June 2017 31
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 32
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, January 2017 - June 2017 33
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), January 2017 - June 2017 34
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 35
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2017 36
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2017 36
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), June 2017 37
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), January 2017 - June 2017 38
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), January 2017 - June 2017 39
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), January 2017 - June 2017 40
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), January 2017 - June 2017 42
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, June 2017 43
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, June 2017 43
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, June 2017 44
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 45
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, June 2017 45
5.1.1 Oncology - Deals of the Month 46
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, June 2017 47
5.2.1 Central Nervous System - Deals of the Month 48
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, June 2017 49
5.3.1 Infectious Diseases - Deals of the Month 50
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, June 2017 51
5.4.1 Cardiovascular - Deal of the Month 52
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, June 2017 53
5.5.1 Immunology - Deals of the Month 54
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, June 2017 55
5.6.1 Gastrointestinal - Deal of the Month 56
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, June 2017 57
5.7.1 Metabolic Disorders - Deal of the Month 58
6 Deal Summary by Geography 59
6.1 Pharmaceuticals & Healthcare, North America Deals, June 2017 59
6.1.1 North America - Deals of the Month 60
6.2 Pharmaceuticals & Healthcare, Europe, Deals, June 2017 61
6.2.1 Europe - Deals of the Month 62
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, June 2017 63
6.3.1 Asia-Pacific - Deals of the Month 64
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, June 2017 65
6.4.1 Rest of the World - Deals of the Month 66
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 67
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, January 2017 - June 2017 67
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, January 2017 - June 2017 68
8 Further Information 69
8.1 Methodology 69
8.2 About GlobalData 70
8.3 Contact Us 70
8.4 Disclosure information 70
8.5 Disclaimer 71

List Of Tables


Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 11
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, June 2017 11
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), June 2017 15
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 16
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, June 2017 17
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, January 2017 - June 2017 18
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 20
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, June 2017 20
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 21
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 22
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, June 2017 23
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, January 2017 - June 2017 24
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), June 2017 25
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 26
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, January 2017 - June 2017 27
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 28
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 29
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 30
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), June 2017 31
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 32
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, January 2017 - June 2017 34
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), January 2017 - June 2017 35
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 36
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 37
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 38
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), June 2017 39
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, January 2017 - June 2017 41
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), June 2017 42
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, June 2017 43
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, June 2017 43
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, June 2017 44
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 46
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 48
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 50
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 52
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 54
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 56
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 58
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 60
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 62
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 64
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 65
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 67
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 68

List Of Figures


Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 10
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), June 2017 14
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), June 2017 15
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 16
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, January 2017 - June 2017 17
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 19
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 21
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 22
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, January 2017 - June 2017 23
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), June 2017 24
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), June 2017 25
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 26
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 28
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 29
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 30
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 32
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, January 2017 - June 2017 33
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, January 2017 - June 2017 34
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 35
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 36
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 37
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 38
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), January 2017 - June 2017 39
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, January 2017 - June 2017 40
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), January 2017 - June 2017 40
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), June 2017 42
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 45
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 47
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 49
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 51
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 53
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 55
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 57
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 59
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 61
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 63
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 65
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 67
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), January 2017 - June 2017 68

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for June 2017 in Pharmaceuticals , report is an essential

USD 1000View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in Pharmaceuticals , report is an essential

USD 1000View Report

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2017

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2017GlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2017 , report is an essential

USD 1500View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in Pharmaceuticals , report is an essential

USD 1000View Report

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2017

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2017GlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2017 , report is an essential

USD 1500View Report

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2017 in PharmaceuticalsGlobalDatas Partnerships, Licensing, Investments and M&A Deals and Trends for April 2017 in Pharmaceuticals report is an essential

USD 1000View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 1000
  • Site Licence    USD 2000
  • Enterprise Wide Licence    USD 3000
$ 1000

Reports Details

Published Date : Aug 2017
No. of Pages :71
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
paykasa bozdurma,paykasa bozdurma,astropay bozdurma,paykasa,paykasa,paykasa bozdurma,paykasa,astropay bozdurma,justin kart,bitcoin bozdurma,paykasa bozum,paykasa kart bozdurma,
beylikduzu escort,bahçeşehir escort,escort istanbul,istanbul escort,sex hikayeleri,pendik escort,
pedalebiellese.com,
istanbul escort bayan,besiktas escort,maltepe escort,kadikoy escort bayan,tekirdag escort bayan,findikzade escort,antalya escort bayan,ankara escort bayan,
Böcek İlaçlama,şehirler arası nakliyat,şehirler arası evden eve nakliyat,ofis taşıma,gebze evden eve nakliyat,kadıköy evden eve nakliyat,istanbul evden eve nakliyat,epoksi zemin,
ankara escort,ankara escort,ankara escort,
tipobet,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop